C. Quinion

发表

Combination anti-CD74 (milatuzumab) and anti-CD20 (rituximab) monoclonal antibody therapy has in vitro and in vivo activity in mantle cell lymphoma.

J. Byrd, G. Lozanski, M. Prætorius-Ibba, 2008, Blood.

FTY720 increases CD74 expression and sensitizes mantle cell lymphoma cells to milatuzumab-mediated cell death.

J. Byrd, C. Chen, R. Baiocchi, 2011, Blood.

FTY 720 increases CD 74 expression and sensitizes mantle cell lymphoma cells to milatuzumab-mediated cell death

J. Byrd, C. Chen, M. Prætorius-Ibba, 2011 .

Combination anti-CD 74 ( milatuzumab ) and anti-CD 20 ( rituximab ) monoclonal antibody therapy has in vitro and in vivo activity in mantle cell lymphoma

J. Byrd, G. Lozanski, M. Prætorius-Ibba, 2011 .

Human Leukocyte Antigen Type and Posttransplant Lymphoproliferative Disorder

M. Caligiuri, R. Pelletier, R. Baiocchi, 2015, Transplantation.

Results of A Phase I Study of Milatuzumab, a Humanized Anti-CD74 Antibody, and Veltuzumab, a Humanized Anti-CD20 Antibody, In Patients with Relapsed and Refractory B-Cell Non-Hodgkin's Lymphoma,

Jeffrey A Jones, J. Byrd, R. Baiocchi, 2010 .

Do Obese Children Have Poor Patient-reported Outcomes After Closed Reduction and Percutaneous Pin Fixation of Supracondylar Humerus Fractures?

Satbir Singh, J. Samora, C. Quinion, 2021, Journal of pediatric orthopedics.

Selective inhibition of protein arginine methyltransferase 5 blocks initiation and maintenance of B-cell transformation.

Claudio Agostinelli, Olivier Elemento, Fengting Yan, 2015, Blood.

Bruton's tyrosine kinase inhibitors in B‐cell non‐Hodgkin's lymphomas

K. Blum, K. Blum, L. Alinari, 2015, Clinical pharmacology and therapeutics.

De novo CD5+ diffuse large B‐cell lymphoma: Adverse outcomes with and without stem cell transplantation in a large, multicenter, rituximab treated cohort

G. Lozanski, A. Evens, K. Blum, 2016, American journal of hematology.